Taking people in JapanNo phase
Observes safety of voclosporin in people with lupus nephritis
Surveys safety of voclosporin use in people with lupus nephritis in routine care.
Plain-language title generated from the registry record
Registry title: LUPKYNIS Drug-use Results Survey
Key facts
- Where
- Osaka, JapanSee the site
Where in Japan
- Pharmacovigilance DepartmentOsaka, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Otsuka Pharmaceutical Co., Ltd.
- Trial code
- NCT07053891
- Record updated
- 20 October 2026
- Original description
The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.Read full original descriptionShow less
LUPKYNIS Drug-use Results Survey
The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.
Inclusion: Patients who are newly starting administration of LUPKYNIS for lupus nephritis.
Exclusion: -.